Biblio
Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic . J Patient Rep Outcomes. 2024;8(1):15.
. . Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013. PLoS One. 2018;13(12):e0208507.